News

Lawsuit alleges Maryland man with diabetes became blind after taking Ozempic
A man who took Ozempic and then became legally blind is suing the manufacturer, arguing it should have warned patients that ...
Say goodbye to cheap versions of Ozempic and Wegovy
This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...
US Man Becomes Blind After Taking Ozempic Due to a Rare Eye Condition
An elderly American man has become completely blind after he was prescribed to take Ozempic to manage his type 2 diabetes.
Novo Nordisk: Examining Tariff And Pricing Risks
Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...
Health and Me on MSN19h
US Man Became Blind After Consuming Ozempic: Do Weight Loss Drugs Cause Blindness?
Todd Engel, a Maryland man, is suing Ozempic maker Novo Nordisk after allegedly going blind due to the drug, raising concerns ...
pharmaphorum22h
Novo Nordisk will file semaglutide for MASH next year
Novo Nordisk's GLP-1 receptor agonist semaglutide ... which is already seeing sales rocket on the back of its use as Ozempic for diabetes, Wegovy for obesity, and label extensions for both brands ...
pharmaphorum22h
FDA fast-tracks GSK’s chronic hep B therapy bepirovirsen
Other drugs in development for CHB include Dicerna (now part of Novo Nordisk) and Roche’s siRNA candidate xalnesiran, which reported phase 2 data at the AASLD conference last year, and Arrowhead ...